I kliniske studier af hypertensive patienter havde Tekturna ingen klinisk signifikant virkning på total kolesterol, HDL- kolesterol, fastende triglycerider, fastende glukose eller urinsyre.
In clinical studies in hypertensive patients, Tekturna had no clinically important effects on total cholesterol, high density lipoprotein cholesterol (HDL-C), fasting triglycerides, fasting glucose or uric acid.